Global law firm Clifford Chance has advised specialized healthcare investor Gilde Healthcare on financing the combined private equity investments in Artinis Medical Systems (Netherlands) and NIRx Medical Technologies (Germany/United States), both pioneers in functional Near-Infrared Spectroscopy (fNIRS) solutions, a differentiated neuroimaging technology. This dual transaction brings together two highly complementary companies, establishing a new global leader in fNIRS.
The investment via two parallel transactions was executed in a proprietary setting, leveraging Gilde’s own developed investment thesis, broad network and deep expertise in the research tools sector